Like the Russian invasion of Ukraine, decimating an independent democracy larger than Germany and the UK combined, reducing its cities to rubble, sending shock waves through the global economy. He’s recommended 24 triple digit winners, and even called the collapse of Lehman Brothers with near-perfect timing.īut he says you likely won’t hear about this “great rotation” happening in the stock market anywhere in the mainstream financial media – until it’s much too late for you to prepare.Īmerica is in grave danger, extremely vulnerable to black swan events that strike out of the blue, that throw the world into turmoil, and that raise the specter of even darker black swans still to come. One legendary market analyst just went “on record” with a stunning interview about what’s happening and what to do.ĭan Ferris has spent 20 years helping people prepare for extreme market shifts at one of the top financial research firms in America… Why is this happening, and what could it mean for your money and retirement? Sure enough, some of the most admired companies for the past decade – like Tesla (TSLA), Nvidia (NVDA), and Moderna (MRNA) – have seen more than a third of their value wiped out, very quickly.Īnd a huge amount of that money is flowing into a different type of investment that’s on an absolute tear today. stock market right now.Īnd Americans who don’t take action could be facing a wipeout like 2008.Ī senior executive at T Rowe Price called it “a regime shift.” Using our analysis, the small-cap hedge fund strategy that we have formulated has outperformed the market by 76.7 percentage points over the 2.5 year period since August 2012.Ī bizarre phenomenon is playing out in the U.S. We looked at the period between 19, and an equally weighted portfolio of 50 most popular hedge fund picks underperformed the market by 7 basis points per month. The $33.36 million company is down nearly 87% during the last 52 weeks.Ĭyclacel Pharmaceuticals Inc (NASDAQ:CYCC) is a small cap company, and our research has shown that small cap picks of hedge funds overwhelmingly outperform the market, as opposed to most popular picks of these investment firms, which mostly tend to be the large cap companies. Alex Denner of Sarissa Capital Management also initiated a stake in Cyclacel Pharmaceuticals Inc (NASDAQ:CYCC) by adding 376,000 shares valued at $263,000 to his portfolio during the fourth quarter. Mintz purchased some 3.2 million shares or 9.3% of the company’s outstanding common stock. ![]() Sabby Capital also initiated a new position in the health sector, represented by Cyclacel Pharmaceuticals Inc (NASDAQ: CYCC), according to a new 13G filing.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |